𝔖 Bobbio Scriptorium

✦ LIBER ✦

38 Biological and biochemical anti-HIV activity of a phosphorothioate G-quartet (TTGGGGTT): R.W. Buckheit, Jr.1, J.R. Roberson1, J.R. Wyatt2, T.A. Vickers2, E. DeBaets2, P.W. Davis2 and D.J. Ecker2, 1Southern Research Institute-Frederick Research Center, Frederick, MD, USA, 2ISIS Pharmaceuticals, Carlsbad, CA, USA

Book ID: 118393484
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 75 KB
Volume: 23
Category: Article
ISSN: 0166-3542
DOI: 10.1016/0166-3542(94)90162-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

33 Temacrazine inhibits initiation of HI

33 Temacrazine inhibits initiation of HIV-1 transcription : J. A. Turpin1,∗ L. Pallansch1, C. Michejda2, W. C. Chlody2, W. G. Rice3 and R. W. Buckheit, Jr.1, 1Southern Research Institute, 3 Achillion Pharmaceuticals, Frederick, MD 21701 2 ABL Basic Research, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, MD 21702

📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 121 KB

19 Anti-HIV-1 activity of a novel nonnuc

19 Anti-HIV-1 activity of a novel nonnucleoside reverse transcriptase inhibitor of HIV-1 (SJ3366 a pyrimidinedione analog) used in combination with other inhibitors of HIV-1 replication : J.D. Russell1, S. Palmer1, R.W. Buckheit1, J-W Lee2, H-H Lee2, J-W Oh2, H-S Kwon2, S-G Chung2 and E-H Cho2. 1Infectious Disease Research Department, Southern Research Institute, Frederick, Maryland, USA; 2Samjin Pharmaceutical Co., Ltd., Seoul, Korea

📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 118 KB

21 Anti-HIV-1 activity of PMEA, PMPA (9-

21 Anti-HIV-1 activity of PMEA, PMPA (9-(2-phosphonylmethoxypropyl)adenine) and AZT against HIV-1 subtypes A, B, C, D, E, F, G and O : S. Palmer1, R. W. Buckheit1, H. Gilbert1, N. Shaw1 and M. D. Miller2 1Infectious Disease Research Department, Southern Research Institute, Frederick, Maryland, USA; 2Gilead Sciences, Foster City, California, USA

📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 118 KB

34 A highly potent NNRTI possessing pote

34 A highly potent NNRTI possessing potential dual activity against HIV-1 reverse transcriptase and a post-attachment intermediate : C. Lackman-Smith1, K. Watson1, J.A. Turpin1, L.A. Pallansch1, S. Kodihalli1, S.-G. Chung2, E.-H. Cho2, and R.W. Buckheit, Jr.1 1Serquest-Southern Research Institute, Frederick, Maryland, USA and 2Samjin Pharmaceutical Co., Ltd., Seoul, Korea

📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 121 KB